4^th Pharmaceutical Chemistry Conference June 27-28, 2019 Amsterdam, Netherlands

Eugen Merkul has completed his PhD with Summa Cum Laude from the University of Düsseldorf/Germany, and Post-doctoral studies from the University of Antwerp/Belgium, followed by industrial experience at German and Dutch Companies. He is the Head of Chemistry of LinXis B.V., an innovative Dutch Biotech Company developing a proprietary ADC (antibody-drug conjugates) platform technology.He is an author/coauthor of 23 papers in reputed peer-reviewed journals and inventor/coinventor of 10 patent applications

Chemistry, Drug Discovery and Therapy